STAT+: FDA advisory panel endorses Moderna mRNA flu vaccine that was subject of controversy

How 1 sources are covering this

• STATCenter·3h ago

  STAT+: FDA advisory panel endorses Moderna mRNA flu vaccine that was subject of controversy

  A panel of advisers to FDA gave its endorsement to a seasonal mRNA flu vaccine that was developed by Moderna and that earlier this year became the subject of controversy.

  Read at STAT →